Clinical Trials Directory

Trials / Recruiting

RecruitingNCT01341327

Observational Study for Left Main Disease Treatment

A GLOBAL, MULTICENTER, PROSPECTIVE, REAL WORLD OBSERVATIONAL STUDY FOR LEFT MAIN DISEASE TREATMENT

Status
Recruiting
Phase
Study type
Observational
Enrollment
10,000 (estimated)
Sponsor
Seung-Jung Park · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to observe clinical courses for long-term in patients with unprotected LMCA disease and to evaluate comparative results of medical treatment, coronary stenting with drug-eluting stents, and CABG for the treatment of an unprotected LMCA stenosis in the "real world" daily practice.

Detailed description

This study is a multicenter, large clinical registry to evaluate comparative outcomes of medical therapy, PCI with DES, or CABG for patients with unprotected LMCA stenosis in the Asia-Pacific, as recorded in the MAIN-IRIS Registry. Data will be prospectively collected on approximately 5000 subjects who diagnosed LM disease (\>50% by visual estimation) at approximately 65 centers in Korea and Asia-Pacific region. Brief study design is as depicted in the following figure

Conditions

Timeline

Start date
2007-07-01
Primary completion
2032-12-01
Completion
2033-12-01
First posted
2011-04-25
Last updated
2026-03-20

Locations

42 sites across 5 countries: China, Malaysia, South Korea, Taiwan, Thailand

Source: ClinicalTrials.gov record NCT01341327. Inclusion in this directory is not an endorsement.

Observational Study for Left Main Disease Treatment (NCT01341327) · Clinical Trials Directory